Efficacy Study of Cognitive Intervention in Amnestic Mild Cognitive Impairment (CogMCI)
2013年8月27日 更新者：Chul Soo Kim、Inha University Hospital
A Multicenter, Randomized Trial to Assess Efficacy of Home-based and Group Cognitive Intervention Programs in Amnestic Mild Cognitive Impairment
- There will be a significant difference in cognitive function between cognitive intervention group (group therapy) and a wait list control group.
- There will be a significant difference in cognitive function between a home-based cognitive intervention group and a wait list control group.
調査の概要
詳細な説明
The change of Modified ADAS-cog score from the baseline to post-intervention will be compared between the cognitive intervention group and wait list control group.
研究の種類
介入
入学 (実際)
293
段階
- 適用できない
連絡先と場所
このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。
研究場所
-
-
-
Ansan、大韓民国
- Korea University Medical College
-
Bucheon、大韓民国、420-767
- Soonchunhyang University Hospital
-
Bucheon、大韓民国
- Bucheon St. Mary's Hospital, The Catholic University of Korea
-
Busan、大韓民国
- Pusan National University Hospital
-
Busan、大韓民国、602-715
- DongA University Hospital
-
Daejun、大韓民国、302-799
- Daejun Eulji University Hopistal
-
Goyang、大韓民国
- NHIC Ilsan Hospital
-
Goyang、大韓民国、412-270
- MyongJi Hospital
-
Incheon、大韓民国、400-711
- Inha Univeristy Hospital
-
Jeju、大韓民国
- Jeju National University Hospital
-
Pusan、大韓民国
- Maryknoll Hospital
-
Seongnam、大韓民国
- bobath Memorial Hospital
-
Seoul、大韓民国
- Inje University Sanggye Paik Hospital
-
Seoul、大韓民国、135-710
- Sungkyunkwan University, Samsung Seoul Hospital
-
Seoul、大韓民国、431-060
- Asan Medical Center, Psychiatry
-
Seoul、大韓民国
- Konkuk University Medical Cener
-
Suwon、大韓民国
- Ajou University Hospital
-
Yongin、大韓民国
- Hyoja Geriatric Hospital
-
-
参加基準
研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。
適格基準
就学可能な年齢
50年～85年 (大人、高齢者)
健康ボランティアの受け入れ
いいえ
受講資格のある性別
全て
説明
Inclusion Criteria:
- 50 to 85 years of age
- memory complaint corroborated by a participant and an informant
- delayed recall score on the Seoul Verbal Learning Test (SVLT) below 1.0 standard deviations from the mean of the age and education-normative values among the Korean population
- Global CDR score is 0.5, Memory CDR score is 0.5 or 1.
- above 1.5 standard deviations from the mean of normative data of the respective age- and education-matched population on the Korean Mini-Mental State Examination
- normal functional activities
- not diagnosed with dementia
- Modified Hachinski Ischemic Score (HIS): 0-4
- brain magnetic resonance imaging or CT showing no clinical evidence of other diseases (i.e., normal pressure hydrocephalus, brain tumor, cerebrovascular disease) capable of producing cognitive impairment.
- Subjects are also required to have a reliable caregiver who meet the patient at least once a week and is sufficiently familiar with the patient to provide the investigator with accurate information.
- He/She can read and write
- written informed consent
Exclusion Criteria:
- any patient who were involved in other clinical trials or treated with experimental drug within 4 weeks
- any patients with any severe or unstable medical disease that may prevent the patient from completing all study requirements (i.e., unstable or severe asthma or cardiovascular disease, active gastric ulcer, severe hepatic or renal disease)
- any patients with clinically significant laboratory abnormalities such as an abnormal thyroid function test, abnormal low level of vitamin B12 or folate, or positive venereal disease research laboratory test
- any patients with any primary neurodegenerative disorder or psychiatric disorder other than AD (i.e., Parkinson's disease, schizophrenia, or major depressive disorder)
- any patients with any history of drug or alcohol addiction during the past 10 years
- any hearing or visual impairment that can disturb the efficient evaluation of the patient
研究計画
このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ：Group cognitive intervention
The cognitive training will be administered twice a week for 12 weeks, located in hospital-based outpatient memory clinics.
Each session will last approximately 90 minutes.
The cognitive training programs will be offered in group sessions consisted of 5 participants.
|
The cognitive training will be administered twice a week for 12 weeks, located in hospital-based outpatient memory clinics.
Each session will last approximately 90 minutes.
The cognitive training programs will be offered in group sessions consisted of 5 participants.
|
|
アクティブコンパレータ：Home-based cognitive intervention
The participants will do their homework for 30 minutes every business days for 12 weeks.
|
The participants will do their paper and pencil homework for 30 minutes every business days for 12 weeks.
|
|
介入なし：Wait list Control
They will participate in cognitive intervention after ending this study.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
時間枠 |
|---|---|
|
Modified Alzheimer's Disease Assessment Scale-Cognitive subscale(ADAS-cog)
時間枠：postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
二次結果の測定
結果測定 |
時間枠 |
|---|---|
|
story recall test
時間枠：postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
Digit span forward and backward
時間枠：postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
Word fluency test
時間枠：postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
color-word stroop test
時間枠：postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
Digit symbol test
時間枠：postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
prospective memory test
時間枠：postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
Mini-Mental State Examination
時間枠：postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
CDR-SB
時間枠：postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
K-AD8
時間枠：postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
PRMQ
時間枠：postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
MMQ-Strategy
時間枠：postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
QOL-AD
時間枠：postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
Geriatric Depression Scale-short form
時間枠：postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
Bayer ADL
時間枠：postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
CGA-NPI
時間枠：postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
|
Subjective cognitive assessment
時間枠：postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
postintervention, 12 weeks follow-up, and 24 weeks follow-up
|
協力者と研究者
ここでは、この調査に関係する人々や組織を見つけることができます。
スポンサー
協力者
捜査官
- 主任研究者：Seong H Choi, MD, PhD、Inha University Hospital
研究記録日
これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。
主要日程の研究
研究開始
2011年3月1日
一次修了 (実際)
2013年1月1日
研究の完了 (実際)
2013年1月1日
試験登録日
最初に提出
2011年5月20日
QC基準を満たした最初の提出物
2011年5月20日
最初の投稿 (見積もり)
2011年5月24日
学習記録の更新
投稿された最後の更新 (見積もり)
2013年8月28日
QC基準を満たした最後の更新が送信されました
2013年8月27日
最終確認日
2013年8月1日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。